In 2023, the global sugar-based excipients market share is projected to reach USD 1,068.41 million, with a steady growth rate ...

This article is authored by Saransh Chaudhary, president, Global Critical Care, Venus Remedies Ltd and CEO, Venus Medicine Research Centre.

Researchers designed oligopeptides that could co-assemble with therapeutic cargoes to create nanoparticles that improved the antitumor efficacy AML model.

New licensing rules mandate compliance with Schedule TB for ASU nasal sprays for patient safety: Shardul Nautiyal, Mumbai Friday, January 24, 2025, 08:00 Hrs [IST] The Union minis ...